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Recent neuroscientific evidence indicates that psychopathy is associated with abnormal
function and structure in limbic and paralimbic areas. Psychopathy and substance use
disorders are highly comorbid, but clinical experience suggests that psychopaths abuse
drugs for different reasons than non-psychopaths, and that psychopaths do not typically
experience withdrawal and craving upon becoming incarcerated. These neurobiological
abnormalities may be related to psychopaths’ different motivations for—and symptoms
of—drug use. This study examined the modulatory effect of psychopathic traits on
the neurobiological craving response to pictorial drug stimuli. Drug-related pictures and
neutral pictures were presented and rated by participants while hemodynamic activity
was monitored using functional magnetic resonance imaging. These data were collected
at two correctional facilities in New Mexico using the Mind Research Network mobile
magnetic resonance imaging system. The sample comprised 137 incarcerated adult
males and females (93 females) with histories of substance dependence. The outcome
of interest was the relation between psychopathy scores (using the Hare Psychopathy
Checklist-Revised) and hemodynamic activity associated with viewing drug-related
pictures vs. neutral pictures. There was a negative association between psychopathy
scores and hemodynamic activity for viewing drug-related cues in the anterior cingulate,
posterior cingulate, hippocampus, amygdala, caudate, globus pallidus, and parts of the
prefrontal cortex. Psychopathic traits modulate the neurobiological craving response and
suggest that individual differences are important for understanding and treating substance
abuse.
Keywords: psychopathic traits, fMRI, drug craving, substance dependence, incarcerated offenders, paralimbic
system
INTRODUCTION
Substance abuse and psychopathy are two conditions strongly
linked to criminal activity. The net annual burden of crime in
the United States alone has been estimated to exceed $3.2 tril-
lion (Anderson, 2011; Kiehl and Hoffman, 2011). Individuals
with psychopathy are among the most dangerous and chronic
offenders, as evidenced by high re-offense rates (Hemphill
et al., 1998; Leistico et al., 2008). Moreover, the use of alco-
hol and drugs greatly increases the likelihood of psychopathic
individuals engaging in serious and/or violent criminal activ-
ity. Indeed, a large scale study on aggression and offending
found that the best predictor of violence was psychopathic
traits in conjunction with alcohol and/or drug abuse (Steadman
et al., 2000). This is particularly disconcerting given the fact
that individuals with psychopathy appear to have a propen-
sity toward substance abuse (Smith and Newman, 1990; Walsh
et al., 2007). One potentially effective way to decrease the eco-
nomic burden of criminal activity in the U.S. would be to
design effective substance use treatments for individuals with
psychopathy.
Psychopathy is characterized by abnormal affective, interper-
sonal, and behavioral functioning. Psychopathic traits include
emotional deficits such as a profound inability to experience
empathy and remorse; behavioral problems such as impulsiv-
ity, stimulation-seeking, and instrumental aggression are also
noted features (Cleckley, 1976; Hare, 2003). Given this behav-
ioral propensity, it should not be surprising that the comorbidity
of psychopathy and substance abuse is high. Relative to non-
psychopathic offenders, research has shown that psychopaths are
more likely to have a diagnosis of drug abuse or dependence
and are more likely to have a polysubstance diagnosis (Smith
and Newman, 1990). An interesting paradox may exist, however.
Though psychopaths are more likely to be diagnosed with drug
use disorders than non-psychopaths, clinical observation suggests
that psychopaths are less likely to experience symptoms such as
withdrawal and craving when access to drugs is externally limited
(e.g., during incarceration) (Cleckley, 1988).
Drug craving is an intense desire or urge to use drugs, and
plays a fundamental role in the maintenance of drug use prob-
lems. Craving has been associated with both repeated drug use
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and relapse after a period of abstinence (cf. Ehrman et al., 1998;
Weiss, 2005). Cue-elicited craving paradigms, where drug cues are
presented and brain activity is recorded using functional imag-
ing techniques, have identified several cortical and subcortical
brain regions related to craving 1: anterior cingulate [Childress
et al., 1999 (cocaine); Filbey et al., 2009 (marijuana); Garavan
et al., 2000 (cocaine); Heinz et al., 2004 (alcohol); Wang et al.,
2011 (heroin); Yin et al., 2012 (methamphetamine)], posterior
cingulate (Wang et al., 2011), orbitofrontal cortex [Bonson et al.,
2002 (cocaine); Sell et al., 2000 (opioids)], insula [Brody et al.,
2002 (nicotine); Myrick et al., 2004 (alcohol); Wang et al., 1999
(cocaine)], ventral and dorsal striatum [David et al., 2005 (nico-
tine); Garavan et al., 2000; Myrick et al., 2004; Wang et al.,
2011] (i.e., nucleus accumbens, caudate, and putamen), thalamus
[Franklin et al., 2007 (nicotine); Wang et al., 2011], and amyg-
dala (Childress et al., 1999; Bonson et al., 2002; Franklin et al.,
2007). However, despite the strong tendency for individuals with
psychopathy to abuse drugs, studies on the neurobiological cor-
relates of craving have not yet examined the potential modulating
effect of psychopathic traits.
An examination of these two separate lines of research sug-
gests there is striking overlap between regions implicated in drug
craving and regions implicated in psychopathy. For instance,
among individuals with psychopathy, reduced amygdala activity
has been reported during aversive delay conditioning (Birbaumer
et al., 2005), emotional memory (Kiehl et al., 2001), and moral
decision-making (Harenski et al., 2010). The orbitofrontal cortex
also has received considerable attention due to its role in impulse
control. One study identified abnormalities in the orbitofrontal
cortex in psychopathic adults during an attention-related task
(Veit et al., 2002). Noting these abnormalities, Blair (2008) pro-
posed that amygdala and orbitofrontal cortex/ventromedial pre-
frontal cortex dysfunction are fundamentally related to the devel-
opment of psychopathy. Other regions have been shown to be
under-reactive, including the anterior cingulate during negative
picture viewing (Muller et al., 2003) and aversive condition-
ing (Veit et al., 2002), the insula during aversive conditioning
(Veit et al., 2002; Birbaumer et al., 2005), the ventral striatum
and posterior cingulate during an emotional memory task (Kiehl
et al., 2001), and the posterior cingulate during emotional moral
decision-making (Glenn et al., 2009). Taken together, these results
lend support to the paralimbic hypothesis of psychopathy (Kiehl,
2006), which states that limbic (e.g., amygdala, hippocampus)
and nearby paralimbic structures (e.g., anterior cingulate, insula,
orbitofrontal cortex) are dysfunctional in response to emotional
and other salient stimuli.
Notwithstanding years of behavioral, psychophysiological, and
now neuroimaging research focusing on reward and punish-
ment processing in psychopathy, the picture is not entirely
clear. Despite clinical observation to the contrary, some stud-
ies have instead suggested a heightened sensitivity to (mone-
tary) reward with higher psychopathic traits (Buckholtz et al.,
2010; Bjork et al., 2012). Another study found a positive cor-
relation between (monetary) gain vs. loss activity in the ventral
1In other words, greater blood oxygenation level dependent response, regional
cerebral blood flow, or glucose metabolism to drug cues vs. neutral cues.
striatum and psychopathy scores in those scoring 30 or above on
the Psychopathy Checklist-Revised (PCL-R) (Hare, 2003; Pujara
et al., 2013). Other studies of youth with disruptive behavior
disorders (e.g., oppositional defiant disorder, conduct disorder,
attention deficit hyperactivity disorder, psychopathic traits) sug-
gest abnormal reward processing (Finger et al., 2008, 2011; White
et al., 2013). The present study was undertaken in an effort to
clarify how psychopathic traits in adults are related to neural
responses to drug cues specifically, given increased drug use but
decreased craving and withdrawal among psychopaths.
Studies indicate that individuals with psychopathy start using
substances at an earlier age (Corrado et al., 2004) and are more
likely to develop polysubstance dependence (Smith and Newman,
1990; Mailloux et al., 1997), but clinical observation points to
less craving and withdrawal (Cleckley, 1988). The present study
utilized fMRI and a cue-elicited drug craving paradigm to exam-
ine the modulatory effect of psychopathic traits on the neu-
robiological craving response in a sample of 137 incarcerated
offenders. Participants viewed drug-related and non-drug pic-
tures, and indicated their level of craving for each picture. Since
psychopaths tend not to experience withdrawal and craving and
the regions engaged during drug craving overlap considerably
with the regions implicated as being deficient in psychopathy,
we expected to see reduced craving-related activity in paralim-
bic, limbic, and subcortical areas among participants with higher
scores on the PCL-R. These areas included the anterior cingu-
late, insula, amygdala, dorsal and ventral striatum, thalamus, and
orbitofrontal cortex.
MATERIALS AND METHODS
PARTICIPANTS
These data were drawn from a National Institute on Drug Abuse
(NIDA)-funded substance abuse treatment trial conducted at two
adult correctional facilities in New Mexico. To be eligible, par-
ticipants had to volunteer, meet DSM-IV (American Psychiatric
Association, 1994) criteria for lifetime dependence on metham-
phetamine, heroin, or cocaine, and had to have used the drug
within 3 months prior to their incarceration. Participants were
given drug tests before each treatment session2, but due to ethical
considerations, were given the opportunity to continue treatment
and study participation regardless of test results. Exclusion cri-
teria included: estimated full-scale IQ less than 70, less than a
sixth grade reading level, current antipsychotic medication use,
psychotic disorder diagnosis for self or a first-degree relative, or
past or current central nervous system disease. Five participants
were excluded due to motion during scanning or poor image
quality (e.g., deformations due to dental work). The final sample
consisted of 137 individuals (mean age = 34.03, SD = 8.18; 93
females; see Table 1 for race/ethnicity). Participants gave written
informed consent and were compensated $1 per hour, commen-
surate with the rate of pay for labor inside correctional facilities.
Study materials and procedures were approved by the UNMHSC
Institutional Review Board.
2Substance abuse treatment began within 1 week of the initial fMRI scan,
barring personal or institutional circumstances (e.g., participant sickness,
institutional lock-down) that precluded the participant from keeping the
appointment.
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Table 1 | Descriptive statistics (N = 137; males, females, and full sample) for demographic, cognitive, psychopathy, and substance use
measures.
Variable Males Females t-statistic df p-value Full sample
(n = 44) (n = 93) (n = 137)
DEMOGRAPHIC
Age 34.18 (8.76) 33.96 (7.93) 0.15 135 0.881 34.03 (8.18) 20–55
Handedness 0.220c
Right 86.4% 79.6% 81.8%
Left 6.8% 10.8% 9.5%
Both/either 6.8% 3.2% 4.4%
Unavailable 0.0% 6.4% 4.4%
Ethnicity 0.266c
Hispanic/latino 54.5% 65.6% 62.0%
Not hispanic/latino 45.4% 32.2% 36.5%
Unavailable 0.0% 2.2% 1.4%
Race <0.001c
White 54.5% 48.4% 50.4%
American Indian or Alaska native 2.3% 6.4% 5.1%
Asian 0.0% 1.1% 0.7%
Black or African American 9.1% 4.3% 5.8%
Other 2.3% 28.0% 19.7%
Did not wish to provide or unavailable 31.8% 11.8% 18.2%
IQa 98.00 (13.32) 94.77 (8.05) 1.48 58.5 0.143 95.82 (10.12)
74–120 74–117 74–120
PSYCHOPATHY (PCL-R)
Total 22.62 (7.42) 19.00 (5.09) 2.92 62.8 0.005 20.17 (6.15)
7.0–36.8 4.4–28.4 4.4–36.8
skew = −0.16 skew = −0.43 skew = 0.06
Factor 1 6.81 (3.41) 4.42 (2.40) 4.19 63.7 <0.001 5.19 (2.97)
0.0–14.0 0.0–12.0 <0.001 0.0–14.0
skew = 0.16 skew = 0.63 skew = 0.69
Factor 2b 13.38 (3.71) 12.66 (3.03) 1.20 134 0.230 12.89 (3.27)
4.0–20.0 4.4–19.0 4.0–20.0
skew = −0.50 skew = −0.38 skew = −0.37
SUBSTANCE USE
Drug of choice 0.496c
Methamphetamine 43.2% 49.5% 47.4%
Cocaine 36.4% 37.6% 37.2%
Heroin 20.5% 12.9% 15.3%
Number of dependence diagnoses 2.64 (1.40) 2.69 (1.22) −0.22 135 0.826 2.67 (1.28)
Years of regular used 44.58 (22.65) 39.59 (21.76) 1.22 131 0.224 41.20 (22.09)
PCL-R, Psychopathy Checklist-Revised (Hare, 2003). df, degrees of freedom. Data are presented as means with standard deviations in parentheses, unless otherwise
noted. Ranges and skewness values are also given for relevant variables. Levels of significance are for two-tailed independent samples t-tests, unless otherwise
noted. Significant p-values are denoted with bold type.
aOne female was missing an IQ estimate.
bOne female had too many Factor 2 items omitted to calculate a score.
cFisher’s exact test p-value.
dFour participants were missing the years of regular use measure (three female).
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ASSESSMENTS
Psychopathy
Psychopathy was assessed using the Hare Psychopathy
Checklist-Revised (Hare, 2003) (PCL-R). Trained researchers
reviewed institutional records and conducted semi-structured
interviews regarding participants’ psychosocial histories and
interpersonal and emotional skills. Individuals are rated on a
3-point scale for 20 items, with scores ranging from 0 to 40.
Traditional factor analyses of the PCL-R have revealed a two-
factor structure (Harpur et al., 1989; Hare, 2003), although other
models have been developed (Cooke and Michie, 2001), includ-
ing a four facet model (Hare, 2003). Factor 1 (potential range:
0–16) comprises interpersonal (e.g., grandiosity, deceitfulness;
Facet 1) and affective traits (e.g., lack of empathy, shallow affect;
Facet 2), and Factor 2 (potential range: 0–20) comprises lifestyle
behavioral (e.g., impulsivity, stimulation-seeking; Facet 3) and
antisocial traits (e.g., poor behavioral controls, early behavioral
problems; Facet 4). Interviews were videotaped to conduct
reliability assessments. Double ratings were conducted on 16.8%
of the sample, selected randomly. The intraclass correlation
coefficient (ICC1one-way random effects model) was 0.83.
Substance use
Substance use was assessed in two ways:
(1) Number of Substance Dependence Diagnoses. Trained
researchers interviewed participants using the Structured
Clinical Interview for DSM-IV disorders (First et al., 1997)
(SCID) to assess lifetime dependence according to DSM-IV
criteria. The total number of substances including alcohol
for which an individual met lifetime dependence criteria was
calculated (scale: 0–8).
(2) Years of Regular Substance Use. A modified version of the
Addiction Severity Index (McLellan et al., 1992) (ASI) was
used to calculate the cumulative years of regular use (i.e.,
three or more times per week) for all substances (alcohol,
heroin, cocaine, methamphetamine, cannabis, hallucino-
gens, and inhalants) combined. The ASI is a brief interview
that asks details about the duration, frequency, and amount
of use of multiple types of drugs.
Other measures
Vocabulary and Matrix Reasoning subtests of the Wechsler Adult
Intelligence Scale (Wechsler, 1997) were used to estimate the full-
scale IQ (Ryan et al., 1999). The Wide Range Achievement Test
Word Reading subtest (Wilkinson, 1993) (WRAT-3) was used to
assess reading level. The SCID was used to assess past and current
Axis I disorders. Individuals self-reported their primary drug of
choice (i.e., methamphetamine, cocaine, or heroin). See Table 1
for descriptive statistics on demographic and study variables.
STIMULI AND TASK
Imaging data were collected prior to the participants’ initiating
the study’s 12-week treatment program. Two types of pictures
(32 drug-related and 32 neutral) were selected from the popular
media. Drug-related pictures depicted drugs or drug parapher-
nalia related to cocaine, heroin, and/or methamphetamine (e.g.,
white powder with a razor blade, a hand holding a syringe, a pipe).
Neutral pictures depicted non-drug objects and scenes (e.g., white
fluffy clouds, folded hands, a pen). Participants were instructed
that they would see a series of pictures presented one at a time
for 6 s. For each picture they were told to determine if anything
in the picture gave them a craving feeling or desire to use drugs.
Then they were instructed to rate their intensity of drug craving
(in the form of a growing red bar) on a scale from 1 (no craving)
to 5 (extreme craving) based on their immediate level of desire,
not how they think they should feel or would hope to feel. After
the rating screen, a black screen with a white fixation cross was
presented for 4 s. Twenty null fixation trials the same duration
as picture trials (i.e., picture + rating + fixation = 14 s) were
interspersed randomly. Each participant completed two runs of
52 trials (16 drug-cues, 16 neutral, and 20 null fixation stimuli
per run).
MRI DATA ACQUISITION AND STATISTICAL ANALYSIS
Participants were scanned on the Mind Research Network 1.5T
Siemens Avanto mobile MRI, stationed at the correctional facil-
ities, using an EPI gradient-echo pulse sequence (TR 2000ms,
TE 39ms, flip angle 75◦, FOV 24 × 24 cm, 64 × 64 matrix, 3.8 ×
3.8mm in-plane resolution, 4mm slice thickness with 1mm gap,
27 slices).
Data were preprocessed and analyzed using Statistical
Parametric Mapping software (SPM5; http://www.fil.ion.ucl.ac.
uk/spm). The ArtRepair Toolbox (Mazaika et al., 2009) was
used to detect and remove severe image artifacts. ArtRepair-
detected artifactual images were replaced and a regressor was
created to remove the effects of the outliers in the statisti-
cal analyses. Following ArtRepair each run was realigned using
INRIAlign, a motion-correction algorithm that is unbiased by
local signal changes (Freire et al., 2002). The six realignment
parameters (three translations and three rotations) and second-
order movement parameters were entered as covariates in the
statistical models below in order to remove variance due to
movement. Realigned images were spatially normalized to the
Montreal Neurological Institute (MNI) template and smoothed
with an 8mm full-width at half-maximum (FWHM) Gaussian
smoothing kernel. Low frequency noise was removed using a
high pass filter (cutoff: 1/128 s). Pictures (drug-related and neu-
tral), ratings, and null fixation trials were modeled separately.
Pictures were modeled with the standard SPM hemodynamic
response function. For each participant, images that represented
the hemodynamic response associated with viewing drug-related
vs. neutral pictures were computed.
One-sample t-tests in SPM5 were used to detect differences
in viewing drug-related pictures vs. neutral pictures (i.e., main
effects), and multiple regression analyses were used to evalu-
ate the relationship between psychopathy and the neural asso-
ciates of drug craving. PCL-R Total score was the predictor of
most interest. PCL-R factors and facets were also examined to
observe the unique variance accounted for by each factor or
facet.
In addition to the primary regression analyses (one for PCL-R
Total score, one for the factors, and one for the facets), three sup-
plementary analyses were performed to evaluate the robustness
of the effect of PCL-R Total score on the hemodynamic response
to drug-related stimuli after including potential covariates (i.e.,
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participant sex, age, number of substance dependence diagnoses).
Additionally, one supplementary analysis was performed to
ensure that the effects of interest were not due to the fact that
some subjects had a positive (n = 11) or invalid/missing (n = 11)
urinalysis just prior to the first treatment session. All whole-brain
analyses were thresholded at p < 0.005 uncorrected for multiple
comparisons with an extent of 10 voxels.
Regions of interest (ROIs) from the previously-cited crav-
ing and psychopathy literatures were evaluated using anatom-
ical small volume correction analyses with PCL-R Total score
as the predictor of interest and no covariates. These regions
were: anterior cingulate, posterior cingulate, medial and lateral
orbitofrontal cortex, amygdala, insula, hippocampus, thalamus,
and parts of the basal ganglia (caudate, putamen, globus pal-
lidus, and nucleus accumbens). ROIs were created using WFU
PickAtlas (Maldjian et al., 2003) and the automated anatomical
labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002) in SPM5. An
ROI was created for each region in each hemisphere, with the
exception of structures that fall on the midline of the brain (i.e.,
anterior cingulate, posterior cingulate, and medial orbitofrontal
cortex).
RESULTS
CORRELATIONS
PCL-R Total score was significantly positively related to the two
substance use variables: number of dependence diagnoses, r =
0.28, p = 0.001 and years of regular use, r = 0.28, p = 0.001.
Factor 1, when controlling for Factor 2, was significantly posi-
tively related to years of regular use, r = 0.21, p = 0.018. Factor 2,
when controlling for Factor 1, was significantly positively related
to the number of dependence diagnoses, r = 0.36, p < 0.001. See
Tables 2, 3 for more.
BEHAVIORAL CRAVING RATINGS
Participants rated drug-related pictures (M = 2.58, SD = 0.96)
as eliciting significantly more craving than neutral pictures [M =
1.51, SD = 0.48; main effect of picture type: F(1, 135) = 174.17,
p < 0.001]. There were no differences in craving by sex [main
effect of sex: F(1, 135) = 1.31, p = 0.255] and no interaction,
F(1, 135) = 1.82, p = 0.181. Additionally, there were no differ-
ences in craving ratings grouped by individuals’ primary drug of
choice, F(2, 134) = 0.74, p = 0.479.
Craving ratings were not significantly related to PCL-R scores,
Total: r = 0.16, p = 0.060; Factor 1: r = 0.03, p = 0.706 (con-
trolling for Factor 2); Factor 2: r = 0.13, p = 0.142 (controlling
for Factor 1). Craving ratings were also not significantly related
to the number of dependence diagnoses, r = 0.15, p = 0.090 or
years of regular use, r = 0.11, p = 0.195.
BRAIN IMAGING
Main effect of picture type
Consistent with previous literature, the comparison of hemo-
dynamic activity associated with viewing drug-related pictures
relative to neutral pictures showed engagement of anterior cingu-
late, bilateral anterior/mid insula, bilateral hippocampus, bilateral
amygdala, posterior cingulate, bilateral striatum (i.e., caudate,
putamen, nucleus accumbens), and bilateral thalamus (Figure 1).
Modulating effects of psychopathy
PCL-R Total scores (whole-brain analyses). As predicted, a sig-
nificant negative association was found between PCL-R Total
scores and hemodynamic activity to drug-related cues in areas
such as the superior and middle frontal gyri, lentiform nucleus
(lateral globus pallidus and putamen), caudate head, anterior
cingulate, precentral gyrus, and inferior parietal lobule (for full
results see Figure 2; Tables 4, A1). There was also one cluster
Table 3 | Pearson product-moment correlations (partial) between
PCL-R factors and assessment variables.
Factor 1, Factor 2,
controlling for controlling for
Factor 2 Factor 1
Age 0.13 −0.23*
IQ −0.03 0.15
Number of dependence diagnoses −0.08 0.36****
Years of regular use 0.21* 0.06
Neutral ratings 0.01 0.03
Craving ratings 0.03 0.13
Craving— neutral (difference scores) 0.03 0.12
*Correlation is significant at the.05 level; ****Correlation is significant at the.001
level. All correlations were two-tailed tests.
Table 2 | Pearson product-moment correlations (zero-order) between PCL-R Total scores and assessment variables.
PCL-R total Age IQ Number of Years of Neutral Craving
dependence diagnoses regular use ratings ratings
Age −0.08
IQ 0.14 0.05
Number of dependence diagnoses 0.28*** 0.11 0.08
Years of regular use 0.28*** 0.46**** 0.02 0.35****
Neutral ratings 0.07 −0.07 0.05 0.14 0.10
Craving ratings 0.16 −0.26** 0.01 0.15 0.11 0.32****
Craving—neutral (difference scores) 0.13 −0.24** −0.02 0.08 0.06 −0.19* 0.87****
*Correlation is significant at the 0.05 level; **Correlation is significant at the 0.01 level; ***Correlation is significant at the 0.005 level; ****Correlation is significant
at the 0.001 level; All correlations were two-tailed tests.
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FIGURE 1 | Main effect of viewing drug-related pictures vs. neutral pictures. These regions are significant in the whole brain at p < 0.005 with a 10 voxel
extent. Numeric values indicate the MNI z-coordinate of the slice, and the color bar represents t-values.
showing a positive association between PCL-R Total scores and
the neural associates of drug craving in the lingual gyrus (BA 18;
x = 18, y = −75, z = −3; k = 20; t = 3.55, p < 0.001).
Three supplementary analyses were performed to con-
trol for the effects of potential covariates (participant sex,
age, number of substance dependence diagnoses) on hemo-
dynamic activity associated with viewing drug-related pic-
tures. Each covariate was added as a nuisance variable to
separate models that compared drug-related pictures to neu-
tral pictures, with PCL-R Total score as the main predic-
tor. Areas that were significant in all four models can be
found in Table 4; other regions are listed in Table A1. A final
supplementary analysis was performed to exclude the poten-
tial effect of active drug use (i.e., those with a positive or
invalid/missing drug urinalysis were not included). There were
negative associations with PCL-R Total scores in superior and
middle frontal areas, the anterior, mid, and posterior cin-
gulate, middle temporal areas, and globus pallidus, caudate,
and putamen (Table A2). A test of the proportion of neg-
ative, positive, and invalid/missing urinalyses in each PCL-
R category (where PCL-R ≤ 20 = low, 20–30 = middle, and
≥ 30 = high) was not significant (p = 0.085, Fisher’s exact
test).
PCL-R factor and facet scores (whole-brain analyses). The neg-
ative effect of psychopathy on the hemodynamic response to
drug-related stimuli was most strongly correlated with the social
deviance factor, Factor 2 (Table A3). In addition to the regions
identified in the analysis with PCL-R Total scores, there was sig-
nificantly reduced engagement of the left amygdala with higher
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Factor 2 scores. There were no negative associations between
Factor 1 (controlling for Factor 2) and viewing drug cues.
There were significant positive associations between neural
activity for viewing drug cues and Factor 1 (controlling for
Factor 2) in the cerebellum, precentral gyrus, lateral globus
FIGURE 2 | Negative associations between PCL-R Total scores and
hemodynamic activity for viewing drug-related pictures vs. neutral
pictures. These regions are significant in the whole brain at p < 0.005 with
a 10 voxel extent. Numeric values indicate the MNI z-coordinate of the
slice, and the color bar represents t-values.
pallidus, middle occipital gyrus, and insula. There were no pos-
itive associations between Factor 2 (controlling for Factor 1) and
neural activity for viewing drug cues.
Relationships between the hemodynamic response to drug-
related stimuli and the PCL-R facets are presented in the
Appendix text (Table A4).
Region of interest analyses. Using small volume correction with
ROIs related to psychopathy and/or drug craving, the right puta-
men and left and right globus pallidus were significantly neg-
atively related to PCL-R Total scores. Additionally, there was
trend-level significance in the anterior cingulate, posterior cin-
gulate, right amygdala, and left thalamus, caudate, putamen, and
nucleus accumbens (Table 5).
DISCUSSION
This study tested the hypothesis that psychopathic traits would
negatively modulate the hemodynamic response to drug-related
stimuli for three types of drugs and different routes of administra-
tion inmale and female substance-dependent inmates. Consistent
with hypotheses, psychopathy scores were negatively associated
with brain engagement to drug-related cues in several limbic
and paralimbic areas, including the anterior cingulate, posterior
cingulate, striatum, and amygdala.
The anterior cingulate is involved in cognitive control, con-
flict monitoring, and error detection (Kiehl et al., 2000; Kerns
et al., 2004). Previous studies have reported less anterior cin-
gulate activity in psychopathy during the performance of var-
ious tasks, including aversive conditioning (Veit et al., 2002;
Birbaumer et al., 2005), negative picture viewing (Muller et al.,
2003) and affective word recognition (Kiehl et al., 2001). Though
cognitive control during a cue-elicited craving task in psy-
chopathy has not been investigated previously, one possibility
is that in the present study, high psychopathy scorers experi-
enced reduced conflict in response to drug cues due to reduced
craving. In other words, unlike low-scorers, those scoring high
on psychopathy did not perceive drug cues to cause cognitive
Table 4 | Negative associations between PCL-R Total scores and hemodynamic activity for viewing drug-related pictures vs. neutral pictures.
Label BA x y z Hemi t-value p-value (unc.) Cluster sizea
Superior frontal gyrus 8 15 30 57 R 4.14 <0.001 283
Middle frontal gyrus 8 −39 21 48 L 3.05 0.001 69
Inferior frontal gyrus 45 45 30 0 R 3.19 0.001 14
Anterior cingulate 32 −15 39 12 L 3.18 0.001 112 (a)
Anterior cingulate 24 −6 33 21 L 3.43 <0.001 112 (a)
Cingulate gyrus (Mid) 23 −6 −12 36 L 3.85 <0.001 78 (b)
Posterior cingulate 23 9 −33 33 R 3.35 0.001 78 (b)
Precuneus 31 18 −48 39 R 3.27 0.001 21
Lateral globus pallidus − 15 0 0 R 3.50 <0.001 173 (c)
Lateral globus pallidus − −18 −3 6 L 3.81 <0.001 173 (c)
These areas are significant across four separate models: PCL-R Total score only, PCL-R Total score and participant sex, PCL-R Total score and age, PCL-R Total score
and number of substance dependence diagnoses. BA, Brodmann Area; Hemi, Hemisphere. Coordinates are in MNI space. Areas are significant at uncorrected p <
0.005, extent threshold = 10 voxels.
aCluster sizes are given for the PCL-R Total score only model. Letters in parentheses indicate a single cluster with multiple peak coordinates.
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Table 5 | Small volume correction associations between PCL-R Total scores and hemodynamic activity for viewing drug-related pictures vs.
neutral pictures in anatomical regions of interest (ROIs).
Region x y z FWE p-value FDR p-value t-value Cluster size
Anterior cingulate −6 33 21 0.084 0.080 3.43 832
Posterior cingulate 6 −36 30 0.096 0.083 3.00 244
R Amygdala 30 −3 −21 0.069 0.187 2.69 75
L Thalamus −15 −6 6 0.083 0.181 3.07 351
L Caudate −6 3 6 0.061 0.073 3.21 292
R Putamen 24 6 −3 0.084 0.046 3.09 312
L Putamen −18 0 9 0.099 0.089 3.01 293
L Nucleus accumbens −6 9 −9 0.081 0.064 2.15 17
R Globus pallidus 15 0 0 0.009 0.009 3.50 82
L Globus pallidus −18 −3 6 0.004 0.005 3.81 86
R, right; L, left; FWE, family-wise error. FDR, false discovery rate. Coordinates are in MNI space. Entries in bold face type are significant at a corrected threshold of
p < 0.05; entries in italics are significant at a corrected threshold of p < 0.10 (i.e., trend level). ROIs that did not produce significant results were: lateral and medial
orbitofrontal cortex, left amygdala, left and right hippocampus, left and right insula, right thalamus, right caudate, and right nucleus accumbens.
conflict. Alternatively, it may be that gray matter abnormali-
ties lead to less hemodynamic activity in the anterior cingulate
cortex. At least two studies have associated psychopathy with
reduced gray matter in the anterior cingulate in adult males
(Boccardi et al., 2011; Ly et al., 2012). The specificity of hemo-
dynamic abnormalities in the anterior cingulate remains an open
question.
The amygdala is responsible for placing emotional signifi-
cance on associations between relevant stimuli (Everitt et al.,
2003). Drug craving involves engagement of the amygdala, in
part because of the acquired emotional significance of drug cues
(Everitt and Wolf, 2002). The negative correlation between psy-
chopathy scores and amygdala reactivity to drug cues is consistent
with the well-documented dysfunction of this region in psy-
chopathy during aversive conditioning (Birbaumer et al., 2005),
emotional word recognition (Kiehl et al., 2001), and moral
decision-making (Harenski et al., 2010). Blair (2008) and oth-
ers (Kiehl, 2006) have identified amygdala dysfunction as being
central to the development of psychopathy.
Engagement of parts of the basal ganglia and striatum while
viewing drug-related cues was negatively related to psychopathy
scores. These brain areas are involved in drive-related behav-
ior and take part in making associations between stimuli and
rewards. The ventral striatum (i.e., nucleus accumbens), includ-
ing the region where the putamen and head of the caudate
meet, receives projections from the amygdala (Nolte, 2002). One
possibility here is that the amygdala is not signaling the emo-
tional significance of rewarding stimuli to the same extent in
high psychopathy-scorers compared to low-scorers, and thus the
regions in the basal ganglia and striatum are under-reactive to
drug-related cues. Other work has suggested instead a heightened
sensitivity to reward with higher psychopathic traits (Buckholtz
et al., 2010; Bjork et al., 2012), but these studies differed crucially
from the present work in that both utilized community volunteers
without histories of substance use. Future work involving connec-
tivity analyses could address these alternative interpretations.
There was also a negative relationship between psychopathy
scores and hemodynamic activity to drug cues in the posterior
cingulate. Prior research demonstrated that smokers trying to
resist cue-elicited craving showed engagement of the posterior
cingulate (Brody et al., 2007). Thus, PCL-R low-scorers may have
engaged the posterior cingulate in order to suppress their crav-
ing response. In contrast, high-scorers had less posterior cingulate
engagement because there was less craving to inhibit. Another
explanation for attenuated posterior cingulate engagement to
drug cues may be that individuals higher in psychopathy have less
graymatter volume in the posterior cingulate overall (Ermer et al.,
2012).
Whereas PCL-R Total score showed the strongest negative
correlations with drug-related hemodynamic activity, the social
deviance component of the PCL-R (Factor 2) and the lifestyle and
antisocial facets (Facet 3 and 4) appeared to be more strongly
correlated with drug-related hemodynamic activity than were
the affective and interpersonal components of psychopathy (i.e.,
Factor 1 and Facets 1 and 2). Factor 2 (and Facet 4 in particular)
has sometimes been criticized for capturing only the behavioral
consequences of the Factor 1 personality traits that some argue are
more central to the concept of psychopathy (Cooke and Michie,
2001), but it is important to note that effects observed in the
present study cannot be explained by general social deviance
per se. The lifestyle facet of psychopathy, Facet 3, includes items
related to chronic instability and impulsivity. Impulsivity, partic-
ularly the shortsightedness aspect, has always been important to
the construct of psychopathy (Hare, 2003), and at least one study
found significant correlations between components of impulsiv-
ity (e.g., nonplanning impulsivity) and PCL-R Factor 2 scores
(Snowden and Gray, 2011).
With respect to the negative relationship between drug-related
hemodynamic activity and Facet 4 of psychopathy it is impor-
tant to keep a few ideas in mind. Whereas Facet 4 was originally
labeled the antisocial facet of psychopathy, it includes the PCL-
R items that directly assess severe behavioral problems that arise
early in life [i.e., early behavioral problems before age 12 (PCL-
R item 10)], persist through adolescence [i.e., severe juvenile
delinquency (PCL-R Item 18)], and continue into adulthood
[i.e., many antisocial behaviors (PCL-R Item 20); failure during
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conditional release (PCL-R Item 19)]. Thus, Facet 4 is the only
facet of psychopathy that represents the developmental course of
the condition.
One possible explanation for the present neuroimaging results
comes from the incentive sensitization theory of addiction
(Robinson and Berridge, 1993), which describes three distinct
processes involved in the development of reward learning: (1)
pleasure (i.e., “liking”), (2) associative learning of the link between
targets and their hedonic value, and (3) attribution of incentive
salience to those targets (i.e., “wanting/craving”). Distinct neural
systems mediate these processes, allowing for differential expres-
sion and behavior. In individuals who are addicted to drugs, it
is thought that increased incentive salience (process #3) medi-
ates compulsive drug-seeking and drug-taking (Robinson and
Berridge, 1993). The self-reported subjective pleasure associated
with drug-taking (process #1) does not become sensitized. This
distinction is supported by individuals’ reports that they like
drugs less and less the more they take them, but they want the
drugs more and more (i.e., craving).
Evidence primarily from animal studies indicates that incen-
tive salience attribution is mediated by the mesocorticolimbic
dopamine system (Berridge, 2009), involving the nucleus accum-
bens, amygdala, hippocampus, and medial prefrontal cortex,
including the anterior cingulate. Keeping in mind the develop-
mental aspect of Facet 4, perhaps psychopaths’ incentive salience
(i.e., “wanting” system) fails to be sensitized due to abnormal
neurodevelopment in critical areas, while the motivating factor
is positive reinforcement for drugs’ pleasurable effects. Thus, rel-
ative to non-psychopaths, psychopaths may have different moti-
vations for using drugs, where craving does not act as a potent
motivator (see also Berridge, 2012). Our finding that higher
psychopathy scores are associated with reduced hemodynamic
activity in response to drug cues is consistent with the expla-
nation that psychopaths experience reduced or absent incentive
salience sensitization, and therefore reduced craving when access
to drugs is externally limited (e.g., during incarceration). Future
work should attempt to clarify how drug craving is related to the
different components of psychopathy.
Because craving has been shown to be a predictor of relapse
(Weiss, 2005), future studies should consider examining the role
of psychopathic traits in drug treatment efficacy. Psychopathic
traits appear to be important variables to consider when design-
ing treatment strategies, as these data demonstrate differences
in response to drug cues with different levels of psychopathic
traits, and indicate the possibility of differences in the time course
of—and reasons for—drug relapse. In terms of generalizability
of findings, the sample comprised mostly polydrug users (mean
number of substance dependence diagnoses = 2.7), which is
more common than single drug use among treatment seekers
(SAMHSA, 2011). The present sample is thus representative of
the typical drug user.
CONCLUSIONS
Numerous functional imaging studies have associated psychopa-
thy with dysfunction in limbic and paralimbic regions, many
of which have also been implicated in drug craving. This study
found a negative association between psychopathy scores and
engagement of craving-related areas during the viewing of drug
cues. Abnormal activity in limbic and paralimbic areas in psy-
chopathy has been demonstrated in multiple domains, including
moral decision-making (Harenski et al., 2010), fear conditioning
(Birbaumer et al., 2005), emotional memory (Kiehl et al., 2001),
and now responses to drug cues. It will be important to follow
up on the present line of work in order to develop more effective
and efficient drug abuse treatments by considering an individual’s
level of psychopathy when determining the most effective treat-
ment strategy. This work has the potential to reduce the extreme
burden—both financial and otherwise—of drug use disorders.
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APPENDIX
Psychopathic Traits Modulate Brain Responses to Drug Cues in Incarcerated Offenders.
Table A1 | Negative associations between PCL-R Total scores and hemodynamic activity for viewing drug-related pictures vs. neutral pictures
in areas that were not significant in all four models (PCL-R Total score only, PCL-R Total score and participant sex, PCL-R Total score and age,
PCL-R Total score and number of substance dependence diagnoses) (cf. Table 4).
%Label BA x y z Hemi t-value p-value (unc.) Cluster sizea In other models?
Superior frontal gyrus 6 −9 −3 66 L 2.97 0.002 10 (a) ∧
Middle frontal gyrus 46 −39 36 27 L 2.81 0.003 15 #∧
Middle frontal gyrus 9 30 42 42 R 3.94 <0.001 283 #∧
Inferior frontal gyrus 9 −57 9 30 L 2.99 0.002 16 (b) #
Inferior frontal gyrus 9 −48 12 27 L 2.80 0.003 16 (b) *
Precentral gyrus 9 −42 3 42 L 3.07 0.001 69 #∧
Precentral gyrus 6 45 −6 24 R 3.31 0.001 10 (c) ∧
Cingulate gyrus (mid) 24 3 −21 36 R 3.04 0.001 78 #∧
Inferior parietal lobule 40 −39 −60 42 L 3.27 0.001 24 *#
Inferior parietal lobule 40 −51 −42 36 L 3.01 0.002 46 (d) #
Inferior parietal lobule 40 −48 −39 45 L 2.98 0.002 46 (d) #∧
Superior temporal gyrus 39 48 −51 12 R 3.16 0.001 11 @
Middle temporal gyrus – 54 −36 −6 R 2.70 0.004 13 %
Caudate (head) – −6 3 6 L 3.21 0.001 173 *
Putamen – −18 15 6 L 3.11 0.001 10 (e) #∧
BA, Brodmann Area; Hemi, Hemisphere. Coordinates are in MNI space. Areas are significant at uncorrected p < 0.005, extent threshold = 10 voxels.
aCluster sizes are given for the PCL-R Total score only model.Letters in parentheses distinguish different clusters of the same size or indicate a single cluster with
multiple peak coordinates.
@Present when including PCL-R Total score only.
*Present when including PCL-R Total score and participant sex.
#Present when including PCL-R Total score and age.
∧Present when including PCL-R Total score and number of substance dependence diagnoses.
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Table A2 | Negative associations between PCL-R Total scores and hemodynamic activity for viewing drug-related pictures vs. neutral pictures
in participants with a valid, negative urinalysis at baseline screening (n = 115).
Label BA x y z Hemi t-value p-value (unc.) Cluster sizea
Superior frontal gyrus 6 15 27 57 R 3.87 <0.001 55 (a)
10 −24 48 18 L 3.37 0.001 85 (b)
9 30 45 36 R 3.60 <0.001 74 (c)
Middle frontal gyrus 10 27 54 24 R 2.83 0.003 74 (c)
8 39 30 48 R 2.88 0.002 74 (c)
9 −42 33 30 L 3.38 0.001 44
9 −36 12 36 L 3.64 <0.001 53 (d)
9 −42 6 42 L 3.01 0.002 53 (d)
8 21 33 48 R 2.81 0.003 55 (a)
47 −42 33 −3 L 3.18 0.001 12 (e)
Precentral gyrus 4 30 −21 48 R 3.96 <0.001 16
Anterior cingulate 32 −15 39 12 L 3.60 <0.001 85 (b)
32 −9 36 21 L 3.32 0.001 85 (b)
Cingulate gyrus (mid) 24 3 −21 36 R 3.74 <0.001 94 (f)
23 −6 −12 36 L 3.71 <0.001 94 (f)
Posterior cingulate 23 9 −33 30 R 3.69 <0.001 94 (f)
Precuneus 31 3 −51 30 R 3.18 0.001 15
31 18 −48 39 R 3.43 <0.001 21
Superior temporal Gyrus 39 48 −51 9 R 3.39 <0.001 17
Middle temporal Gyrus 22 48 −39 0 R 3.02 0.002 31 (g)
20 54 −39 −9 R 3.35 0.001 31 (g)
21 51 −18 −18 R 3.59 <0.001 37
21 −63 −36 −12 L 3.51 <0.001 77 (h)
21 −60 −24 −18 L 3.07 0.001 77 (h)
20 −51 −33 −12 L 3.18 0.001 77 (h)
Supramarginal gyrus 40 −42 −48 36 L 2.83 0.003 19 (i)
Inferior parietal lobule 40 −39 −39 30 L 3.57 <0.001 19(i)
40 −48 −39 45 L 3.02 0.002 12 (j)
40 −39 −60 39 L 3.00 0.002 10
Lateral globus pallidus – 15 0 0 R 3.25 0.001 36
Caudate (head) – −3 3 6 L 3.49 <0.001 45
Putamen – −21 −3 3 L 3.21 0.001 19
BA, Brodmann Area; Hemi, Hemisphere. Coordinates are in MNI space. Areas are significant at uncorrected p < 0.005, extent threshold = 10 voxels. aLetters in
parentheses distinguish different clusters of the same size or indicate a single cluster with multiple peak coordinates.
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Table A3 | Associations between PCL-R factor scores and hemodynamic activity for viewing drug-related pictures vs. neutral pictures.
Label BA x y z Hemi t-value p-value (unc.) Cluster sizea
Factor 1 Positive* Precentral gyrus 6 39 −12 45 R 3.28 0.001 11
Insula 13 −39 −9 3 L 3.09 0.001 13
Middle occipital gyrus 18 15 −102 12 R 3.40 <0.001 12
Lateral globus pallidus – −21 −12 −9 L 3.30 0.001 11
Culmen (cerebellum) – 18 −33 −21 R 3.35 0.001 30
– −24 −39 −24 L 3.25 0.001 14
Factor 2 Negative Medial frontal gyrus 6 −12 −12 63 L 4.25 <0.001 100
Superior frontal gyrus 6 15 −18 69 R 3.04 0.001 19 (a)
6 15 24 57 R 3.30 0.001 108 (b)
6 −12 21 54 L 2.87 0.002 19 (c)
10 −18 48 18 L 2.72 0.004 116 (d)
8 18 36 48 R 4.16 <0.001 108 (b)
8 −6 27 57 L 3.06 0.001 19 (c)
8 −18 15 45 L 2.75 0.003 19 (c)
Middle frontal gyrus 8 −30 18 51 L 3.39 <0.001 23
9 27 36 39 R 3.23 0.001 108 (b)
9 −39 9 36 L 2.92 0.002 48 (e)
46 −39 15 24 L 3.17 0.001 48 (e)
6 −36 −3 48 L 3.17 0.001 17 (f)
Inferior frontal gyrus 46 45 36 3 R 3.35 0.001 24 (t)
Precentral gyrus 6 −27 −21 63 L 3.07 0.001 12 (g)
6 −24 −21 72 L 2.72 0.004 12 (g)
Postcentral gyrus 2 −60 −30 45 L 3.15 0.001 18 (h)
3 15 −42 72 R 3.51 <0.001 15
Parahippocampal gyrus 36 27 −27 −18 R 4.16 <0.001 28
Hippocampus – 27 −39 −6 R 4.04 <0.001 21
Amygdala – −30 0 −27 L 3.62 <0.001 33
Anterior cingulate 32 −18 39 12 L 3.83 <0.001 116 (d)
32 −9 9 36 L 3.23 0.001 19 (i)
24 −3 27 18 L 4.2 <0.001 116 (d)
Cingulate gyrus (mid) 24 −6 −12 39 L 3.82 <0.001 80 (j)
24 9 −12 36 R 3.28 0.001 80 (j)
Posterior cingulate 31 12 −42 39 R 3.35 0.001 106 (k)
31 3 −45 33 R 3.29 0.001 106 (k)
Inferior parietal lobule 40 −39 −57 42 L 3.24 0.001 17 (l)
40 42 −36 30 R 3.98 <0.001 22
Superior temporal gyrus 39 54 −57 12 R 3.13 0.001 24 (m)
22 45 0 −3 R 2.90 0.002 12 (n)
Middle temporal gyrus 37 54 −63 3 R 2.86 0.002 24 (m)
Transverse temporal gyrus 41 −39 −33 9 L 3.42 <0.001 16
Insula 13 −39 −12 6 L 3.11 0.001 32 (o)
13 −39 −3 0 L 2.81 0.003 32 (o)
Middle occipital gyrus 18 −9 −93 12 L 2.96 0.002 19 (p)
Cuneus 17 −3 −93 0 L 2.81 0.003 19 (p)
Lateral globus pallidus – −21 −15 −9 L 3.67 <0.001 77 (q)
Medial globus pallidus – −15 −3 0 L 3.32 0.001 77 (q)
Caudate (tail) – −33 −15 −12 L 3.19 0.001 77 (q)
Caudate (head) – 12 12 6 R 2.93 0.002 28 (r)
Caudate (body) – 9 3 6 R 2.90 0.002 28 (r)
Claustrum – 36 −21 3 R 3.37 <0.001 32 (o)
– 36 −3 3 R 2.82 0.003 12 (n)
– −36 −21 0 L 2.85 0.003 17 (s)
BA, Brodmann Area; Hemi, Hemisphere. Coordinates are in MNI space. Areas are significant at uncorrected p < 0.005, extent threshold = 10 voxels. *Each
coordinate is in a different cluster.
aLetters in parentheses distinguish different clusters of the same size or indicate a single cluster with multiple peak coordinates.
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Table A4 | Associations between PCL-R facet scores and hemodynamic activity for viewing drug-related pictures vs. neutral pictures.
Label BA x y z Hemi t-value p-value (unc.) Cluster sizea
Facet 1 Positive Postcentral gyrus 2 51 −24 51 R 3.53 <0.001 75 (a)
Precentral gyrus 4 36 −18 63 R 3.50 <0.001 75 (a)
Superior temporal gyrus 22 60 0 −3 R 3.76 <0.001 17
22 −57 −6 −3 L 3.09 0.001 16
Insula 13 45 −9 9 R 3.42 <0.001 11 (b)
Parahippocampal gyrus 36 −27 −39 −9 L 2.85 0.003 59 (c)
Uncus 20 −33 −6 −33 L 3.35 0.001 23 (d)
36 −24 −3 −36 L 2.76 0.003 23 (d)
Putamen – −27 −15 −6 L 3.29 0.001 13
Thalamus – 21 −30 9 R 3.24 0.001 28
Culmen (cerebellum) – −24 −36 −21 L 3.44 <0.001 59 (c)
– −30 −51 −30 L 2.73 0.004 59 (c)
– 18 −33 −18 R 3.10 0.001 11 (e)
Facet 2 Positive Cuneus 18 18 −78 21 R 3.40 <0.001 11
Lateral globus pallidus – 21 −6 −6 R 3.02 0.001 10
Negative Superior frontal gyrus 10 21 51 3 R 3.51 <0.001 26 (f)
Anterior cingulate 32 21 42 3 R 3.35 0.001 26 (f)
Superior temporal gyrus 38 45 12 −27 R 3.53 <0.001 24
22 −57 −54 6 L 3.18 0.001 35 (g)
Middle temporal gyrus 22 −54 −45 0 L 2.98 0.002 35 (g)
38 −36 9 −42 L 3.15 0.001 14 (h)
21 −42 0 −42 L 3.06 0.001 14 (h)
Fusiform gyrus 20 36 −12 −27 R 3.17 0.001 14 (i)
Thalamus – −21 −21 18 L 3.49 <0.001 38
Facet 3 Positive* Medial frontal gyrus 9 12 39 36 R 3.15 0.001 12
Middle frontal gyrus 11 −27 42 −9 L 3.06 0.001 15
Inferior frontal gyrus 47 −45 21 −3 L 3.17 0.001 19
Caudate (body) – 6 12 15 R 3.97 <0.001 31
Culmen (cerebellum) – −3 −33 −21 L 3.18 0.001 12
Negative Medial frontal gyrus 6 −12 −3 66 L 3.89 <0.001 302 (j)
6 −6 −15 63 L 3.77 <0.001 302 (j)
Middle frontal gyrus 6 −36 −3 48 L 3.10 0.001 15
Postcentral gyrus 3 −30 −36 66 L 3.69 <0.001 302 (j)
2 −36 −27 45 L 3.44 <0.001 112 (k)
2 −42 −24 33 L 3.17 0.001 112 (k)
Precentral gyrus 6 39 −9 45 R 3.63 <0.001 22
Anterior cingulate 32 −15 33 18 L 3.27 0.001 11
24 −9 6 39 L 2.94 0.002 50 (l)
Cingulate gyrus 24 −9 −12 39 L 4.15 <0.001 50 (l)
Posterior cingulate 31 12 −42 42 R 3.03 0.001 88 (m)
Precuneus 7 0 −45 45 – 3.78 <0.001 88 (m)
7 6 −69 51 R 3.01 0.002 13 (n)
Fusiform gyrus 37 −45 −36 −12 L 4.01 <0.001 52 (o)
20 −39 −30 −21 L 3.05 0.001 52 (o)
Middle temporal gyrus 20 −54 −36 −12 L 3.58 <0.001 52 (o)
Transverse temporal Gyrus 41 −33 −33 9 L 3.78 <0.001 38 (p)
Superior temporal gyrus 41 −39 −30 3 L 3.43 <0.001 38 (p)
Inferior parietal lobule 40 −60 −27 33 L 3.69 <0.001 112 (k)
Cuneus 18 3 −84 21 R 3.39 <0.001 64
Lingual gyrus 19 −15 −54 −6 L 3.24 0.001 23
−9 −69 0 L 2.97 0.002 13 (q)
(Continued)
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Table A4 | Continued
Label BA x y z Hemi t-value p-value (unc.) Cluster sizea
Putamen – −33 −21 0 L 3.18 0.001 38 (p)
Substantia nigra – −18 −18 −9 L 4.24 <0.001 25
Culmen (cerebellum) – −24 −51 −18 L 3.07 0.001 10
Facet 4 Positive Insula 13 −30 −12 21 L 3.45 <0.001 10
Negative Inferior frontal gyrus 47 −39 21 −21 L 4.51 <0.001 196 (q)
47 −39 18 −6 L 4.05 <0.001 196 (q)
47 −42 33 −6 L 3.58 <0.001 196 (q)
47 48 36 3 R 4.04 <0.001 89 (r)
45 57 27 15 R 3.92 <0.001 89 (r)
47 42 18 −12 R 2.88 0.002 10 (s)
Medial frontal gyrus 10 3 57 9 R 3.00 0.002 217 (t)
8 −9 24 54 L 3.42 <0.001 19
8 15 30 48 R 4.14 <0.001 75
9 3 45 18 R 4.05 <0.001 217 (t)
Middle frontal gyrus 9 −42 9 39 L 3.15 0.001 27 (u)
9 30 18 36 R 3.65 <0.001 21 (v)
46 −45 21 30 L 2.85 0.003 27 (u)
46 −45 30 18 L 3.08 0.001 16
Anterior cingulate 24 −3 27 27 L 3.66 <0.001 217 (t)
32 −21 42 12 L 3.19 0.001 11
Cingulate gyrus (mid) 24 9 −9 33 R 3.13 0.001 48 (w)
Posterior cingulate 31 6 −45 30 R 3.55 <0.001 21 (x)
29 −6 −51 9 L 3.34 0.001 20
30 9 −51 12 R 3.27 0.001 21 (y)
Amygdala – 27 −3 −24 R 3.35 0.001 26 (z)
Parahippocampal gyrus 35 24 −27 −21 R 3.90 <0.001 104 (aa)
34 18 −9 −21 R 2.75 0.003 26 (z)
27 21 −33 −6 R 3.01 0.002 24 (bb)
Superior temporal gyrus 41 45 −36 9 R 3.19 0.001 10 (cc)
Supramarginal gyrus 40 −51 −48 30 L 3.37 <0.001 25
Cuneus 19 27 −84 27 R 3.21 0.001 13 (dd)
19 27 −87 18 R 2.83 0.003 13 (dd)
Caudate (body) – 15 18 18 R 3.45 <0.001 40 (ee)
– 12 12 9 R 3.03 0.001 40 (ee)
– 15 −15 24 R 2.98 0.002 48 (w)
Thalamus – 0 −12 3 – 3.37 <0.001 34
– 18 −27 3 R 2.83 0.003 24 (bb)
Claustrum – −33 −6 3 L 3.41 <0.001 15 (ff)
Culmen (cerebellum) – 12 −33 −18 R 3.85 <0.001 104 (aa)
BA, Brodmann Area; Hemi, Hemisphere. Coordinates are in MNI space. Areas are significant at uncorrected p < 0.005, extent threshold = 10 voxels. *Each
coordinate is in a different cluster.
aLetters in parentheses distinguish different clusters of the same size or indicate a single cluster with multiple peak coordinates. Coordinates listed under different
facets/directions are in different clusters.
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